It has been a reasonably disappointing start to the week for the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO). In afternoon trade the benchmark index is down 0.2% to 6,018 points.
Four shares which haven't let that hold them back are listed below. Here's why they have started the week with strong gains:
The a2 Milk Company Ltd (Australia) (ASX: A2M) share price is up 3% to $6.90. This morning the dairy company released a presentation and market update for the UBS Australasia conference. According to the update, a2 Milk's estimated share of the Chinese infant formula market has increased to 4.1% from 3.5% previously. The company holds its AGM on November 22.
The Creso Pharma Ltd (ASX: CPH) share price has jumped 10% to 74.6 cents. This morning the medicinal cannabis company announced that it welcomed Canada's new proposed tax regime for recreational cannabis. The Trudeau Government has proposed a tax of C$1 per gram of legalised recreational cannabis. The company expanded into Canada this year and hopes to benefit from its legalisation.
The Lepidico Ltd (ASX: LPD) share price has continued its strong run and is up a further 22% to 4.4 cents. The lithium exploration, development, and production company's shares have now risen over 170% in just one month. The company recently announced a placement of shares with lithium mining giant Galaxy Resources Limited (ASX: GXY). Lepidico is definitely one to watch in the future in my opinion.
The Praemium Ltd (ASX: PPS) share price is up 5% to 64.2 cents after the fintech company advised that funds under administration (FUA) across its global platforms and funds have surpassed $7 billion. Impressively, this means that Praemium has added $1 billion in FUA in less than six months.
